Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥22.94 - CN¥142.00
Next Earnings Date
May 21 2025 (Estimate)
Next Earnings Date
May 21 2025 (Est.)
Latest price
Market Cap | CN¥12.43B |
EV | CN¥11.43B |
Shares Outstanding | 89.58M |
Beta | 1.50 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | - |
P/E 2025E | 231.33x |
P/Revenue 2025E | 18.98x |
Revenue | -54.40% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 50.00% |
Net Profit Margin 2025E | 8.55% |
ROE 2025E | 1.70% |
ROCE 2024 | -5.42% |
DPS 2025E | CN¥0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Beijing Hotgen Biotech Co., Ltd.
688068
Sector
Healthcare
Industry
Biotechnology
CEO
Lin, Changqing
Employees
Website
www.hotgen.com.cnIPO Date
2019-09-30
Headquarters
Zhongguancun High-end Medical Device Ind, Building 10, No. 26 Yongwang West Road, Daxing District, Beijing 102629, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved